Giant Bicycle Recalls Momentum Vida E+ E-Bikes Due to Crash Hazard
No injuries reported. This is a preventive recall action.
Giant Bicycle Recalls Momentum Vida E+ E-Bikes Due to Crash Hazard
Giant Bicycle Inc., of Newbury Park, California · Momentum Vida E+ E-Bikes




Product Description
This recall involves the Momentum Vida E+ E-bike. The bicycles come in metallic red, pearl white, metallic navy blue, metallic green, indigo blue, happy mint (light green) and panther (black). The bicycle comes in two frame configurations (mid-step and low-step) and both configurations come in small, medium and large sizes. The unique serial number for each bike is stamped into the frame on the outer side of the left rear dropout and on a printed sticker under the bike's downtube. "Momentum" is written on the downtube of the bicycle and "Vida E+" is written on the top tube.
Hazard
The fork steerer tube on the recalled bicycles can crack, break or separate during use, posing a fall hazard.
Remedy
To determine whether a Momentum Vida E+ bicycle is included in this recall, consumers should look at the third character of the bike's serial number. Bikes with a serial number in which the third character is "H", "J" or "K" are included in this recall and must have their forks replaced free of charge. Bikes with a serial number in which the third character is "G" require additional visual inspection by an authorized Giant Bicycle dealer to determine fork status.
Reported Injuries
The firm has received four reports of broken fork steerer tubes. No injuries have been reported.
411 Press Analysis
Giant Bicycle Inc., of Newbury Park, California has voluntarily recalled about 6,200 of Momentum Vida E+ E-Bikes as a preventive safety measure. The recall was announced by the CPSC on July 10, 2025. The fork steerer tube on the recalled bicycles can crack, break or separate during use, posing a fall hazard. While no injuries have been reported, the identified hazard warrants consumer attention. Affected consumers should receive a free replacement. The CPSC recommends discontinuing use of the product until the remedy has been completed.